Novartis drug Cosentyx fails late-stage trial for artery disease

• click to rate

  Posted by Two Blokes Jul 3 - Filed in Stock - 4 views
  
  Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), a condition characterised by inflammation of the arteries.